Shielding Assessment and Optimization of the Target Station for Medical Isotope Production Based on Superconducting Proton Linac

Author:

Chen Daiyuan1,Augusto Ricardo dos Santos2ORCID,Li Yuanhong1,Qin Zhi3,Rong Jian14,Yao Kaiqiang1,Jia Huan3,Yuan Chenzhang3,Liu Juntao14ORCID,Liu Zhiyi14

Affiliation:

1. School of Nuclear Science and Technology, Lanzhou University, Lanzhou 730000, China

2. Environment, Safety & Health Directorate, TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada

3. Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, China

4. Frontiers Science Center for Rare Isotopes, Lanzhou University, Lanzhou 730000, China

Abstract

In response to the worldwide shortage of 99mTc supply caused by the combined consequence from both decommissioning and maintenance of research reactors worldwide, the Institute of Modern Physics (IMP) of the Chinese Academy of Science and Lanzhou University have launched a collaboration to research and develop a 99mTc production solution based on the 25 MeV high-intensity superconducting proton linear accelerator. Radiation from high-current proton bombardment must be evaluated and considered carefully at the design stage to meet radiation protection (RP) policy and requirements of the shielding for the key device. This work employed FLUKA to conduct the shielding assessment of both prompt and residual radiation fields in several iterations, based on a prototype of the high-power target system. The prompt dose rates outside the target station are lower than the institution’s limit. The residual dose rates inside the station fall below 100 μSv/h at 64 h after the end of beam (EOB); the dominant source term is then the target chamber. The service life of the main actuator is expected to be extended by 2.7 times with the current partial shielding design. The simulation accelerating techniques are applied to balance the accuracy of results and the progress of the project at the same time, which is referential to the shielding assessment of large-scale nuclear facilities. The results can also be used in further study and construction of the target station.

Funder

National Natural Science Foundation of China

Special Projects of the Central Government in Guidance of Local Science and Technology Development

Research and Development of Medical Isotopes based on High-current Superconducting Linear Accelerator Project

Science and Technology Planning Project of Gansu

Lanzhou University Talent Cooperation Research Funds sponsored by both Lanzhou City

Gansu provincial science and technology plan projects for talents

Publisher

MDPI AG

Subject

Fluid Flow and Transfer Processes,Computer Science Applications,Process Chemistry and Technology,General Engineering,Instrumentation,General Materials Science

Reference25 articles.

1. (2022, March 02). Radioisotopes in Medicine. Available online: https://www.world-nuclear.org/information-library/non-power-nuclear-applications/radioisotopes-research/radioisotopes-in-medicine.aspx.

2. Accelerating production of medical isotopes;Ruth;Nature,2009

3. Development of radioisotopes preparation technology in China;Huang;J. Isot.,2019

4. National Academies of Sciences, Engineering, and Medicine (2016). Molybdenum-99 for Medical Imaging, The National Academies Press.

5. Organization for Economic Cooperation and Development/Nuclear Energy Agency (2019). The Supply of Medical Radioisotopes: An Economic Diagnosis and Possible Solutions, OECD Publishing.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3